An Eye Drug Used Off-Label for Two Decades Now Has Formal Approval for Wet Macular Degeneration

The FDA approved the first ophthalmic bevacizumab for wet AMD on July 24. What the end of two decades of off-label use means for patients.

Have A Referral?